Journey Strategic Wealth’s MaxLinear MXL Stock Holding History

Journey Strategic Wealth’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,420	Closed	-$258K	–	222
2021 Q4	$258K	Buy	+3,420	New	+$219K	0.03%	143

Other funds holding MXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CCM

Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Journey Strategic Wealth's MXL Position: Q1 2022 in Review

Journey Strategic Wealth sold out of MaxLinear (MXL) in Q1 2022, closing a stake of 3,420 shares — an estimated $258K sold.

Journey Strategic Wealth first reported a position in MXL in Q4 2021 and held it in 1 quarter. The position peaked at $258K in Q4 2021. 293 funds tracked by Wall St. Rank hold MXL as of Q1 2022.

Journey Strategic Wealth reported no remaining MaxLinear position as of Q1 2022 after selling out during the quarter.
Journey Strategic Wealth sold 3,420 MaxLinear shares in Q1 2022, an estimated $258K.
Journey Strategic Wealth first reported a position in MaxLinear in Q4 2021 and held it in 1 quarter.
Journey Strategic Wealth's MaxLinear position peaked at $258K in Q4 2021.
293 funds tracked by Wall St. Rank held MaxLinear as of Q1 2022.

Based on Journey Strategic Wealth's 13F filing for Q1 2022, filed 16 May 2022.